MMDA Stats & Data
COc1cc(CC(C)N)cc2OCOc12YQYUWUKDEVZFDB-UHFFFAOYSA-NPharmacology
DrugBankDescription
MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a member of the amphetamine drug class with stimulant and psychedelic properties. It also acts as an entheogen and an entactogen. MMDA bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. The effects of MMDA includes feelings of euphoria and warmth, as well as realistic closed-eye visuals.
Mechanism of Action
The mechanism that produces the psychedelic activity of MMDA has not been definitively established. There are, as of the present time, no reported studies on the human pharmacokinetics or metabolism of MMDA. Based on its structural relationship with other similar drugs for which the pharmacology is known, it is likely that MMDA has multiple mechanisms of action, and probably acts both as a 5HT2A agonist in a similar manner to hallucinogenic amphetamines such as DOM, and also as a serotonin releaser by reversing the direction of the serotonin reuptake transporter in a similar manner to MDMA.
Indication
MMDA is a recreational drug. It has no current medical uses and is a Schedule I controlled substance in the USA at present.
Effect Profile
Curated + 4 ReportsMild visuals with strong body load, low headspace
Strong sensory enhancement and euphoria with moderate stimulation
Strong euphoria with strong anxiety/jitters, moderate focus and stimulation
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Experience Report Analysis
ErowidDemographics
Gender Distribution
Too few reports for a chart: gender is known from 5 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Male 4 of 5
- Not Specified 1 of 5
Age Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 4 experience reports (4 single-substance Erowid)
Effect Sentiment Distribution
Confidence Distribution
Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.
Too few reports for bars: these effects come from 4 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?
Positive Effects 7
Adverse Effects 1
Show 1 neutral or unclassified mention
Form / Preparation
Most common forms and preparations, as a share of the 4 reports that give one
Too few reports for bars: these forms come from 4 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?
- Powder / Crystals 2 of 4
- Capsule 2 of 4